Dr Lorch is Medical Director of Richmond Pharmacology in London (UK). She is a Fellow of the Royal College of Anaesthetists and a Fellow of the Faculty of Pharmaceutical Medicine, holding its specialist accreditation. She has special expertise in early phase integrated, adaptive study designs in healthy volunteers and patients, including first-in-human (FIH). Ulrike represents early phase stakeholders at the EMA on the update to the FIH guideline and the new EU Clinical Trial Regulation.